ZNF570 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.953000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.986800E-01
Normal-vs-Stage2
2.749000E-01
Normal-vs-Stage3
3.311700E-02
Normal-vs-Stage4
5.257400E-01
Stage1-vs-Stage2
5.149600E-01
Stage1-vs-Stage3
1.290980E-01
Stage1-vs-Stage4
2.240400E-01
Stage2-vs-Stage3
2.298600E-01
Stage2-vs-Stage4
3.512400E-02
Stage3-vs-Stage4
1.047700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.784600E-01
Normal-vs-AfricanAmerican
8.294000E-01
Normal-vs-Asian
1.296580E-01
Caucasian-vs-AfricanAmerican
5.772200E-01
Caucasian-vs-Asian
2.845000E-01
AfricanAmerican-vs-Asian
2.512000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.226600E-01
Normal-vs-Female
2.680200E-01
Male-vs-Female
7.271800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.680600E-01
Normal-vs-Age(41-60Yrs)
3.687200E-01
Normal-vs-Age(61-80Yrs)
2.989200E-01
Normal-vs-Age(81-100Yrs)
6.361900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.397400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.822000E-04
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.438300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.876800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.441800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.779800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.074770E-01
Normal-vs-Daily Drinker
1.157750E-03
Normal-vs-Weekly Drinker
1.923220E-01
Normal-vs-Occasional Drinker
3.734000E-01
Normal-vs-Social Drinker
6.435800E-01
Non Drinker-vs-Daily Drinker
2.870200E-02
Non Drinker-vs-Weekly Drinker
6.436200E-01
Non Drinker-vs-Occasional Drinker
2.453200E-01
Non Drinker-vs-Social Drinker
2.648000E-01
Daily Drinker-vs-Weekly Drinker
1.800350E-02
Daily Drinker-vs-Occasional Drinker
6.335000E-03
Daily Drinker-vs-Social Drinker
3.143900E-02
Weekly Drinker-vs-Occasional Drinker
5.680000E-01
Weekly Drinker-vs-Social Drinker
4.593600E-01
Occasional Drinker-vs-Social Drinker
7.410000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.103570E-01
Normal-vs-Grade 2
6.915700E-02
Normal-vs-Grade 3
7.956400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.196600E-01
Grade 1-vs-Grade 3
7.966400E-01
Grade 1-vs-Grade 4
1.103570E-01
Grade 2-vs-Grade 3
9.368200E-01
Grade 2-vs-Grade 4
6.915700E-02
Grade 3-vs-Grade 4
7.956400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.990200E-01
Normal-vs-NonDiabetic
1.272610E-01
Diabetic-vs-NonDiabetic
4.195800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.790100E-02
Normal-vs-NoPancreatitis
1.967240E-01
Pancreatitis-vs-NoPancreatitis
1.042430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.694800E-01
Normal-vs-N1
2.730600E-01
N0-vs-N1
9.652600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.149400E-01
Normal-vs-TP53-NonMutant
5.836800E-01
TP53-Mutant-vs-TP53-NonMutant
8.233600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
